The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
TG Therapeutics, Inc(NASDAQ:TGTX) 
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclon...
Website: http://www.tgtherapeutics.com
Founded: 1993
Full Time Employees: 217
Sector: Healthcare
Industry: Biotechnology
TG Therapeutics Days Payable Outstanding ttm (DPO)
TG Therapeutics Days Receivable Outstanding ttm (DSO)
TG Therapeutics Days Inventory Outstanding ttm (DIO)
TG Therapeutics Op Cashflow Per Share ttm
TG Therapeutics Free Cashflow Per Share ttm
TG Therapeutics Cash Per Share ttm
TG Therapeutics P/S ratio ttm
TG Therapeutics (GAAP) P/E ratio ttm
TG Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.